TELA Bio, Inc. (TELA)
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
TELA Bio, Inc.
NASDAQ:TELAHealthcare · Medical - Devices
-11.95%$0.8101
AH$0.8101+0.00%vs close
Mkt Cap$36.57M
Float36.89M
O/S45.14M
Vol
$ Vol
RVOL
Inst Own57.0%
SI1.7%
Earnings
Dilution
Financials Summary
Revenue$80.28M
Net Income-$38.83M
Total Assets$81.42M
Free Cash Flow-$28.67M
Debt & Equity
Debt 90%
Equity 10%
Total Debt$55.65M
Total Equity$6.31M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:250Reverse splitOct 15, 2007250 shares → 1
Balance Sheet Details
Assets$81.42M
Liabilities$75.11M
Accounts Receivable$10.35M
Accounts Payable$2.31M
Inventory$11.02M
PP&E (Net)$3.73M
Goodwill$0
Intangible Assets$1.36M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Revenue | $80.28M | $69.3M | $58.45M | $41.42M | $29.46M | $18.21M | $15.45M | $8.27M | $4.25M |
| YoY Growth | 15.8% | 18.6% | 41.1% | 40.6% | 61.8% | 17.9% | 86.7% | 94.9% | - |
| Cost of Revenue | $25.93M | $22.81M | $18.34M | $14.37M | $10.65M | $6.98M | $6.17M | $5.33M | $1.71M |
| Gross Profit | $54.34M | $46.49M | $40.11M | $27.04M | $18.81M | $11.23M | $9.27M | $2.94M | $2.53M |
| Gross Margin | 67.7% | 67.1% | 68.6% | 65.3% | 63.9% | 61.7% | 60.0% | 35.6% | 59.6% |
| Research and Development | $9.22M | $8.81M | $9.62M | $8.94M | $6.74M | $4.25M | $4.15M | $4.34M | $5.79M |
| Selling, General, and Administrative | $78.88M | $79.37M | $74.57M | $57.11M | $41.52M | $32.25M | $24.28M | $18.55M | $13.67M |
| Other | $0 | -$7.58M | $0 | $0 | $0 | $0 | $0 | $70K | $94K |
| Total Operating Expenses | $88.1M | $80.6M | $84.19M | $66.05M | $48.26M | $36.51M | $28.43M | $22.88M | $19.46M |
| Operating Income (EBIT) | -$33.76M | -$34.12M | -$44.08M | -$39.01M | -$29.45M | -$25.27M | -$19.16M | -$17.78M | -$16.92M |
| Operating Margin | -42.0% | -49.2% | -75.4% | -94.2% | -100.0% | -138.8% | -124.1% | -214.9% | -398.7% |
| Interest Expense | $5.25M | $5.29M | $5.22M | $4.05M | $3.6M | $3.56M | $3.61M | $1.8M | $4.56M |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$4.85M | -$3.87M | -$2.59M | -$5.29M | -$3.83M | -$3.52M | -$3.26M | -$3.31M | -$4.41M |
| Income Before Tax (EBT) | -$38.6M | -$37.98M | -$46.66M | -$44.3M | -$33.28M | -$28.79M | -$22.43M | -$21.09M | -$21.33M |
| Income Tax Expense | $230K | -$144K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$38.83M | -$37.84M | -$46.66M | -$44.3M | -$33.28M | -$28.79M | -$22.43M | -$21.09M | -$21.33M |
| Net Income Margin | -48.4% | -54.6% | -79.8% | -106.9% | -112.9% | -158.1% | -145.2% | -254.9% | -502.6% |
| Supplementary Data | |||||||||
| EPS | -0.83 | -1.33 | -2.04 | -2.73 | -2.30 | -2.23 | -2.26 | -3.25 | -3.29 |
| Diluted EPS | -0.83 | -1.33 | -2.04 | -2.73 | -2.30 | -2.23 | -2.26 | -3.25 | -3.29 |
| Weighted Average OS | 46.95M | 28.53M | 22.87M | 16.27M | 14.47M | 12.93M | 11.41M | 6.49M | 6.49M |
| EBITDA | -$32.35M | -$31.68M | -$40.63M | -$39.06M | -$29.14M | -$24.7M | -$18.23M | -$18.04M | -$16.02M |
| EBITDA Margin | -40.3% | -45.7% | -69.5% | -94.3% | -98.9% | -135.6% | -118.0% | -218.1% | -377.3% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Assets | |||||||||
| Current Assets | |||||||||
| Cash and Cash Equivalents | $50.84M | $52.67M | $46.73M | $42.02M | $43.93M | $74.39M | $45.3M | $17.28M | $11.35M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $9.29M | $0 | $0 |
| Cash and Short-Term Investments | $50.84M | $52.67M | $46.73M | $42.02M | $43.93M | $74.39M | $54.59M | $17.28M | $11.35M |
| Accounts Receivable | $10.35M | $10.1M | $9.74M | $6.62M | $4.23M | $2.68M | $2.84M | $1.3M | $757K |
| Inventory | $11.02M | $12.78M | $13.16M | $11.79M | $7.66M | $3.91M | $4.6M | $4.35M | $1.81M |
| Other Current Assets | $3.37M | $2.52M | $2.1M | $2.02M | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | $75.58M | $78.07M | $71.73M | $62.45M | $59.05M | $83.22M | $64.33M | $23.25M | $14.35M |
| Long-Term Assets | |||||||||
| Property, Plant & Equipment Net | $3.73M | $4.08M | $3.94M | $2.91M | $1.19M | $626K | $677K | $758K | $1.16M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $1.36M | $1.74M | $2.12M | $2.5M | $2.3M | $2.61M | $2.91M | $3.21M | $0 |
| Long-Term Investments | $250K | $2.54M | $265K | $0 | $0 | $0 | $0 | $0 | $24K |
| Deferred Tax Assets | $0 | $896K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $500K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Assets | $5.84M | $9.25M | $6.32M | $5.41M | $3.49M | $3.23M | $3.59M | $3.97M | $1.19M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $81.42M | $87.33M | $78.05M | $67.86M | $62.54M | $86.46M | $67.92M | $27.23M | $15.53M |
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts Payable | $2.31M | $2.15M | $1.67M | $1.53M | $2.41M | $652K | $3.17M | $3.42M | $1.51M |
| Short-Term Debt | $0 | $545K | $565K | $340K | $0 | $0 | $0 | $0 | $905K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.59M |
| Other Current Liabilities | $15.67M | $5.56M | $5.52M | $4.11M | $3.15M | $2.24M | $1.19M | $985K | $1.94M |
| Total Current Liabilities | $17.98M | $15.6M | $16.97M | $12.4M | $10.57M | $6.61M | $6.71M | $9.56M | $6.15M |
| Long-Term Liabilities | |||||||||
| Long-Term Debt | $55.65M | $41.12M | $40.52M | $39.92M | $31.49M | $30.83M | $30.24M | $29.73M | $3.61M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $756K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $1.48M | $0 | $0 | $31K | $380K | $0 | $4K | $125.8M | $113.94M |
| Total Long-Term Liabilities | $57.13M | $43.27M | $42.2M | $41.15M | $31.87M | $30.83M | $30.25M | $155.53M | $117.56M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $75.11M | $58.87M | $59.17M | $53.55M | $42.45M | $37.43M | $36.96M | $165.09M | $123.7M |
| Stockholders' Equity | |||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $124.15M | $111.35M |
| Common Stock | $44K | $39K | $24K | $19K | $15K | $14K | $11K | $0 | $7K |
| Retained Earnings | -$397.56M | -$358.73M | -$320.89M | -$274.23M | -$229.93M | -$196.65M | -$167.86M | -$137.86M | -$108.17M |
| Comprehensive Income & Other | $91K | $90K | $91K | $150K | -$52K | -$71K | -$19K | -$3.24M | -$2.79M |
| Other Stockholders' Equity | $403.83M | $387.15M | $339.75M | $288.51M | $250.01M | $245.66M | $198.81M | $0 | -$7K |
| Total Equity | $6.31M | $28.46M | $18.88M | $14.3M | $20.1M | $49.03M | $30.96M | -$137.86M | -$108.17M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $81.42M | $87.33M | $78.05M | $67.86M | $62.54M | $86.46M | $67.92M | $27.23M | $15.53M |
| Supplementary Data | |||||||||
| Total Debt | $55.65M | $43.06M | $42.77M | $41.46M | $31.49M | $30.83M | $30.24M | $29.73M | $4.51M |
| Net Debt | $4.81M | -$9.61M | -$3.96M | -$563K | -$12.44M | -$43.57M | -$15.06M | $12.46M | -$6.83M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Operating Activities | |||||||||
| Net Income | -$38.83M | -$37.84M | -$46.66M | -$44.3M | -$33.28M | -$28.79M | -$22.43M | -$21.09M | -$21.33M |
| Depreciation & Amortization | $1.01M | $1.01M | $808K | $1.19M | $535K | $525K | $582K | $1.25M | $761K |
| Deferred Income Tax | $230K | -$144K | $0 | $0 | $14K | $0 | $5K | $1.22M | -$40K |
| Stock-Based Compensation | $3.8M | $4.36M | $5.03M | $3.99M | $3.66M | $2.06M | $457K | $216K | $197K |
| Changes in Working Capital: | |||||||||
| Accounts Receivable | -$110K | -$762K | -$3.06M | -$2.42M | -$1.55M | $149K | -$1.53M | -$541K | -$578K |
| Inventory | -$503K | -$2.97M | -$2.72M | -$6.07M | -$5.19M | -$620K | -$1.84M | -$4.76M | -$127K |
| Accounts Payable | $141K | $482K | $11K | -$884K | $1.6M | -$2M | -$773K | $1.91M | -$748K |
| Other Working Capital | $1.97M | -$1.62M | $4.1M | $3.62M | $1.69M | $2.39M | -$2.1M | -$1.07M | $1.53M |
| Total Working Capital Change | $1.5M | -$4.87M | -$1.67M | -$5.76M | -$3.47M | -$86K | -$6.24M | -$4.46M | $75K |
| Other Non-Cash Items | $4.08M | -$4.12M | $1.64M | $4.13M | $2.1M | $1.84M | $2.09M | $2.94M | $3.97M |
| Net Cash from Operating | -$28.22M | -$41.59M | -$40.86M | -$40.75M | -$30.43M | -$24.46M | -$25.52M | -$19.92M | -$16.37M |
| Investing Activities | |||||||||
| Capital Expenditures | -$448K | -$989K | -$611K | -$872K | -$627K | -$167K | -$2.7M | -$1.56M | -$114K |
| Acquisitions | $1.29M | $0 | $0 | $0 | $0 | $0 | $0 | $4K | $13K |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | -$9.28M | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $9.29M | $0 | $0 | $0 |
| Other Investing Activities | $0 | $5.44M | $12K | -$1M | $0 | $0 | $0 | $4K | $13K |
| Net Cash from Investing | $846K | $4.45M | -$599K | -$1.87M | -$627K | $9.12M | -$11.98M | -$1.56M | -$101K |
| Financing Activities | |||||||||
| Debt Repaid | -$14.03M | - | - | -$10M | - | - | - | -$25M | -$12.2M |
| Common Stock Issuance | $11.82M | $42.92M | $46.34M | $34.4M | $585K | $44.72M | $51.15M | $2.41M | $14.14M |
| Common Stock Repurchases | $105K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$205K | $138K | -$74K | -$3.55M | $0 | -$313K | $14K | -$1.56M | $14.14M |
| Net Cash from Financing | $25.75M | $43.06M | $46.27M | $40.85M | $585K | $44.41M | $65.53M | $27.41M | $26.34M |
| Forex Effect | -$217K | $28K | $164K | -$144K | $11K | $17K | -$4K | $0 | $0 |
| Net Change in Cash | -$1.84M | $5.94M | $4.97M | -$1.91M | -$30.46M | $29.09M | $28.02M | $5.93M | $9.87M |
| Supplementary Data | |||||||||
| Operating Cash Flow | -$28.22M | -$41.59M | -$40.86M | -$40.75M | -$30.43M | -$24.46M | -$25.52M | -$19.92M | -$16.37M |
| Capital Expenditure | -$448K | -$989K | -$611K | -$1.87M | -$627K | -$167K | -$2.7M | -$1.56M | -$114K |
| Free Cash Flow | -$28.67M | -$42.58M | -$41.47M | -$42.62M | -$31.06M | -$24.62M | -$28.22M | -$21.49M | -$16.48M |
| Cash at Beginning | $52.94M | $46.99M | $42.02M | $43.93M | $74.39M | $45.3M | $17.28M | $11.35M | $1.48M |
| Cash at End | $51.09M | $52.94M | $46.99M | $42.02M | $43.93M | $74.39M | $45.3M | $17.28M | $11.35M |